(ACN) Accenture - Overview
Stock: Strategy, Consulting, Technology, Operations, AI
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.30% |
| Yield on Cost 5y | 2.62% |
| Yield CAGR 5y | 13.87% |
| Payout Consistency | 99.0% |
| Payout Ratio | 46.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.8% |
| Relative Tail Risk | -6.18% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.44 |
| Alpha | -52.03 |
| Character TTM | |
|---|---|
| Beta | 0.841 |
| Beta Downside | 0.914 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.02% |
| CAGR/Max DD | -0.09 |
Description: ACN Accenture January 27, 2026
Accenture plc (NYSE: ACN) is a global professional-services firm that delivers strategy, consulting, digital, technology, and operations solutions across 10+ industry verticals. Its portfolio spans systems integration, cloud-native application management, cybersecurity, AI-driven data platforms, and automation hardware (e.g., robotics), as well as managed business-process services for finance, procurement, supply chain, marketing, and HR. The company’s client base includes communications, financial services, health, consumer goods, industrial, and energy sectors, with notable collaborations such as its joint go-to-market with Amazon Web Services for public-sector digital transformation and a partnership with OpenAI to embed generative-AI agents into enterprise workflows.
Key recent metrics (FY 2023 ended 31 Dec 2023) show Accenture generated $61.6 billion in revenue, a 10.5 % year-over-year increase driven largely by cloud services (+15 % YoY) and AI-related engagements (+23 % YoY). Operating margin held at 14.5 % (stable versus FY 2022), and diluted earnings per share rose to $12.55. Analyst consensus projects FY 2024 revenue growth of 8-9 % as corporate IT spend is expected to expand ~5 % annually, with AI-enabled automation cited as a primary growth catalyst in the IT consulting sub-industry.
For a deeper, data-rich assessment of Accenture’s valuation dynamics, consider exploring the ValueRay platform’s sector-specific risk-adjusted return models.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 7.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 2.67 > 1.0 |
| NWC/Revenue: 11.55% < 20% (prev 12.07%; Δ -0.52% < -1%) |
| CFO/TA 0.19 > 3% & CFO 12.12b > Net Income 7.61b |
| Net Debt (-1.45b) to EBITDA (12.34b): -0.12 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (626.0m) vs 12m ago -1.36% < -2% |
| Gross Margin: 31.93% > 18% (prev 0.32%; Δ 3160 % > 0.5%) |
| Asset Turnover: 113.6% > 50% (prev 110.8%; Δ 2.71% > 0%) |
| Interest Coverage Ratio: 39.97 > 6 (EBITDA TTM 12.34b / Interest Expense TTM 263.9m) |
Altman Z'' 3.74
| A: 0.13 (Total Current Assets 28.07b - Total Current Liabilities 19.90b) / Total Assets 64.70b |
| B: 0.34 (Retained Earnings 22.15b / Total Assets 64.70b) |
| C: 0.17 (EBIT TTM 10.55b / Avg Total Assets 62.28b) |
| D: 0.63 (Book Value of Equity 20.55b / Total Liabilities 32.78b) |
| Altman-Z'' Score: 3.74 = AA |
Beneish M -3.02
| DSRI: 1.03 (Receivables 16.01b/14.57b, Revenue 70.73b/66.36b) |
| GMI: 1.02 (GM 31.93% / 32.47%) |
| AQI: 0.98 (AQ_t 0.50 / AQ_t-1 0.51) |
| SGI: 1.07 (Revenue 70.73b / 66.36b) |
| TATA: -0.07 (NI 7.61b - CFO 12.12b) / TA 64.70b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of ACN shares?
Over the past week, the price has changed by -8.73%, over one month by -12.29%, over three months by +0.28% and over the past year by -36.48%.
Is ACN a buy, sell or hold?
- StrongBuy: 12
- Buy: 6
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ACN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 292 | 21.3% |
| Analysts Target Price | 292 | 21.3% |
| ValueRay Target Price | 234.4 | -2.6% |
ACN Fundamental Data Overview February 03, 2026
P/E Forward = 19.0476
P/S = 2.3117
P/B = 5.2082
P/EG = 2.0255
Revenue TTM = 70.73b USD
EBIT TTM = 10.55b USD
EBITDA TTM = 12.34b USD
Long Term Debt = 5.03b USD (from longTermDebt, last quarter)
Short Term Debt = 842.9m USD (from shortTermDebt, last quarter)
Debt = 8.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.45b USD (from netDebt column, last quarter)
Enterprise Value = 162.05b USD (163.49b + Debt 8.20b - CCE 9.65b)
Interest Coverage Ratio = 39.97 (Ebit TTM 10.55b / Interest Expense TTM 263.9m)
EV/FCF = 14.08x (Enterprise Value 162.05b / FCF TTM 11.51b)
FCF Yield = 7.10% (FCF TTM 11.51b / Enterprise Value 162.05b)
FCF Margin = 16.28% (FCF TTM 11.51b / Revenue TTM 70.73b)
Net Margin = 10.76% (Net Income TTM 7.61b / Revenue TTM 70.73b)
Gross Margin = 31.93% ((Revenue TTM 70.73b - Cost of Revenue TTM 48.15b) / Revenue TTM)
Gross Margin QoQ = 32.91% (prev 31.89%)
Tobins Q-Ratio = 2.50 (Enterprise Value 162.05b / Total Assets 64.70b)
Interest Expense / Debt = 0.80% (Interest Expense 65.4m / Debt 8.20b)
Taxrate = 24.46% (725.8m / 2.97b)
NOPAT = 7.97b (EBIT 10.55b * (1 - 24.46%))
Current Ratio = 1.41 (Total Current Assets 28.07b / Total Current Liabilities 19.90b)
Debt / Equity = 0.27 (Debt 8.20b / totalStockholderEquity, last quarter 30.87b)
Debt / EBITDA = -0.12 (Net Debt -1.45b / EBITDA 12.34b)
Debt / FCF = -0.13 (Net Debt -1.45b / FCF TTM 11.51b)
Total Stockholder Equity = 30.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.22% (Net Income 7.61b / Total Assets 64.70b)
RoE = 24.98% (Net Income TTM 7.61b / Total Stockholder Equity 30.47b)
RoCE = 29.71% (EBIT 10.55b / Capital Employed (Equity 30.47b + L.T.Debt 5.03b))
RoIC = 22.37% (NOPAT 7.97b / Invested Capital 35.62b)
WACC = 8.61% (E(163.49b)/V(171.70b) * Re(9.01%) + D(8.20b)/V(171.70b) * Rd(0.80%) * (1-Tc(0.24)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.89%
[DCF Debug] Terminal Value 76.76% ; FCFF base≈10.53b ; Y1≈11.14b ; Y5≈13.20b
Fair Price DCF = 335.6 (EV 205.09b - Net Debt -1.45b = Equity 206.54b / Shares 615.4m; r=8.61% [WACC]; 5y FCF grow 6.37% → 2.90% )
EPS Correlation: 62.96 | EPS CAGR: 12.42% | SUE: 2.85 | # QB: 1
Revenue Correlation: 86.86 | Revenue CAGR: 6.03% | SUE: 0.92 | # QB: 3
EPS next Quarter (2026-05-31): EPS=3.70 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=21
EPS current Year (2026-08-31): EPS=13.82 | Chg30d=-0.015 | Revisions Net=+14 | Growth EPS=+6.9% | Growth Revenue=+6.0%
EPS next Year (2027-08-31): EPS=14.89 | Chg30d=+0.009 | Revisions Net=+6 | Growth EPS=+7.7% | Growth Revenue=+5.6%